To investigate whether gefitinib could up-regulate surface ligands for NK cell activating receptors, we co-cultured two human lung cancer cell lines with NK cells and evaluated the expression of ULBP1, ULBP2 and MICA by flowcytometry. Here, ULBP2 is linked to lung cancer.